Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers

Background: Comprehensive molecular studies on tumours are needed to delineate immortalization process steps and identify sensitive prognostic biomarkers in thyroid cancer. Methods and results: In this study, we extensively characterize telomere-related alterations in a series of 106 thyroid tumours...

Descripción completa

Detalles Bibliográficos
Autores: Montero-Conde, C. (Cristina)|||/items/6d47bc2d-9ef9-4bfd-b374-e423d15b1a25, Leandro-García, L.J. (Luis J.)|||/items/2b44a058-b84c-4a11-ba79-586cd96d0448, Martínez-Montes, A.M. (Ángel M.)|||/items/b516ac80-4289-4500-bf8d-6020481456a1, Martínez, P. (Paula)|||/items/1d9dee42-36b1-44e9-bbe7-6998383a3bf5, Moya-Faz, F.J. (Francisco José)|||/items/6102aa74-fb85-4e24-a56b-0d455483b283, Leton, R. (Rocío)|||/items/292ea14e-4a9d-44f5-b173-d1a1285e3e25, Gil, E. (Eduardo)|||/items/b4f29bae-0e0f-4bd2-a246-99578b4855ac, Martínez-Puente, N. (Natalia)|||/items/342fc39d-2ebf-41dd-beb9-a9bd4ebea359, Guadalix, S. (Sonsoles)|||/items/59ca9666-3549-43be-b944-428d56084e83, Currás, M. (María)|||/items/da704e52-e034-47bd-9844-b7ce28b1ef2f, Garcia-Tobar, L. (Laura)|||/items/64b398ed-0d60-4773-9118-e862d5d28ff9, Zafón, C. (Carles)|||/items/25a3e6e5-617d-4937-b3ce-7fed784dbb47, Jordá, M. (Mireia)|||/items/3d80cad9-83d9-4ca7-bce9-327e348710c2, Riesco-Eizaguirre, G. (Garcilaso)|||/items/5b966126-3180-4b86-8215-aa6793d1b0d7, García-Montón-González P. (Patricia)|||/items/066b96d4-7696-4d42-8723-7c86875ee1bf, Monteagudo, M. (María)|||/items/13516cb2-250f-4738-961c-d101f67477d7, Torres-Pérez, R. (Rafael)|||/items/a5a8b84f-5a87-4563-8114-2d402eea8f95, Mancikova, V. (Veronika)|||/items/286402de-9eee-4e42-b39a-4ff976fe6d36, Ruiz-Llorente, S. (Sergio)|||/items/94866d6e-caf0-4040-b178-c6702425da61, Martínez-Pérez, J.M. (José Manuel)|||/items/5227974d-c5c8-45d6-a1de-3985e5732b27, Pita, G. (Guillermo)|||/items/511d3d5b-17c7-49eb-99a2-b5e30c36b145, Galofre-Ferrater, J.C. (Juan Carlos)|||/items/e7463ff9-97f4-4119-a307-fd978c0017fd, Gonzalez-Neira, A. (Anna)|||/items/8595341c-963a-4cbe-bdec-8b5267ad1b73, Cascon, A. (Alberto)|||/items/15e22b8d-8e23-4935-a21e-1796f757fa76, Rodriguez-Antona, C. (Cristina)|||/items/7e878c35-4151-4360-800d-066cc7de6740, Megías, D. (Diego)|||/items/d96eda06-62b0-485e-8275-245da5f19ebd, Blasco, M.A. (Maria A.)|||/items/947c369b-148a-4b1e-b1d0-33d7ed216c19, Caleiras, E. (Eduardo)|||/items/a50fa3bb-6348-4b3b-996d-a6bb73dcdd8c, Rodriguez-Perales, S. (Sandra)|||/items/00d786b0-c4eb-4585-8b7a-30c17f7a74af, Robledo, M. (Mercedes)|||/items/3fa84b0c-f9be-49a8-9290-c1c74231ac11
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/122440
Acceso en línea:https://hdl.handle.net/10171/122440
Access Level:acceso abierto
Palabra clave:5p-end FISH
TERC
TERT promoter methylation
TERT promoter mutation
Subtelomeric gene expression
Telomere shortening
Descripción
Sumario:Background: Comprehensive molecular studies on tumours are needed to delineate immortalization process steps and identify sensitive prognostic biomarkers in thyroid cancer. Methods and results: In this study, we extensively characterize telomere-related alterations in a series of 106 thyroid tumours with heterogeneous clinical outcomes. Using a custom-designed RNA-seq panel, we identified five telomerase holoenzyme-complex genes upregulated in clinically aggressive tumours compared to tumours from long-term disease-free patients, being TERT and TERC denoted as independent prognostic markers by multivariate regression model analysis. Characterization of alterations related to TERT re-expression revealed that promoter mutations, methylation and/or copy gains exclusively co-occurred in clinically aggressive tumours. Quantitative-FISH (fluorescence in situ hybridization) analysis of telomere lengths showed a significant shortening in these carcinomas, which matched with a high proliferative rate measured by Ki-67 immunohistochemistry. RNA-seq data analysis indicated that short-telomere tumours exhibit an increased transcriptional activity in the 5-Mb-subtelomeric regions, site of several telomerase-complex genes. Gene upregulation enrichment was significant for specific chromosome-ends such as the 5p, where TERT is located. Co-FISH analysis of 5p-end and TERT loci showed a more relaxed chromatin configuration in short telomere-length tumours compared to normal telomere-length tumours. Conclusions: Overall, our findings support that telomere shortening leads to a 5p subtelomeric region reorganization, facilitating the transcription and accumulation of alterations at TERT-locus.